Unknown

Dataset Information

Targeted nanoparticles for imaging incipient pancreatic ductal adenocarcinoma.


ABSTRACT:

Background

Pancreatic ductal adenocarcinoma (PDAC) carries an extremely poor prognosis, typically presenting with metastasis at the time of diagnosis and exhibiting profound resistance to existing therapies. The development of molecular markers and imaging probes for incipient PDAC would enable earlier detection and guide the development of interventive therapies. Here we sought to identify novel molecular markers and to test their potential as targeted imaging agents.

Methods and findings

Here, a phage display approach was used in a mouse model of PDAC to screen for peptides that specifically bind to cell surface antigens on PDAC cells. These screens yielded a motif that distinguishes PDAC cells from normal pancreatic duct cells in vitro, which, upon proteomics analysis, id

SUBMITTER: Kelly KA 

PROVIDER: S-EPMC2292750 | biostudies-literature | 2008 Apr

REPOSITORIES: biostudies-literature